We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Auricular Stimulation Reduces Cardiac Postoperative AF Risk

By HospiMedica International staff writers
Posted on 06 Nov 2019
Image: Graphical abstract of the study (Photo courtesy of Martin Andreas / MedUniWien).
Image: Graphical abstract of the study (Photo courtesy of Martin Andreas / MedUniWien).
A new study reveals that postoperative atrial fibrillation (POAF) complications could be halved by non-invasive electrical stimulation of the vagus nerve directly on the ear.

Researchers at the Medical University of Vienna (MedUniWien; Austria) conducted a randomized 1:1 study to examine the antiarrhythmic and anti-inflammatory effects of noninvasive low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve in 40 patients slated for cardiac surgery. Following surgery, electrical stimulation electrodes were applied in the triangular fossa of the ear for up to two weeks. Heart rhythm was recorded continuously via Holter electrocardiogram (ECG), and C-reactive protein (CRP) and interleukin-6 plasma concentrations were measured.

The results revealed that the patients receiving LLTS (amplitude one mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break) had a significantly reduced occurrence of POAF (4 of 20 events) when compared with the control group (11 of 20 events) during a similar mean Holter ECG recording period. The median duration of POAF was comparable between the treatment and the control group, and no effect of the LLTS application on CRP or IL-6 levels was detectable. The study was published on October 10, 2019, in Circulation: Arrhythmia and Electrophysiology.

“Electrical stimulation of the ear and the vagus nerve that sits on the surface there has a calming effect, in that we are stimulating the largest nerve of the parasympathetic nervous system and hence the corresponding antagonists,” said lead author Martin Andreas, MD, PhD, of the department of surgery. “This stimulation is given continuously in the first five days after an operation, when the risk of POAF is at its highest, and is then stopped, if everything goes well. The innovative product, from an Austrian company from Mauerbach, has already been successfully used for vascular occlusions.”

POAF occurs in up to 40% of patients undergoing cardiac surgery. Conventional viewpoints suggest that it is less likely to affect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, newer reports suggest that POAF is also associated with a significantly higher incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction.

Related Links:
Medical University of Vienna


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Antimicrobial Mat
MULTIMAT
New
ow Frequency Pulse Massager
ET10 L

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more